$CRCW
Crypto Co Stock $crcw

$crcw Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222032030 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$103.8K	$252.7K	$109.3K
YoY Change	-51.55%	131.33%	1265.63%
Cost Of Revenue	$103.0K	$94.53K
YoY Change	-62.37%
Gross Profit	$750.00	$158.2K	$109.3K
YoY Change	-101.26%	44.8%
Gross Profit Margin	0.72%	62.6%	100.0%
Selling, General & Admin	$588.6K	$487.2K	$519.4K
YoY Change	-15.68%	-6.19%	121.77%
% of Gross Profit	78482.67%	307.97%	475.38%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$21.74K	$32.71K	$0.00
YoY Change	117.18%
% of Gross Profit	2898.67%	20.67%	0.0%
Operating Expenses	$610.4K	$530.8K	$519.4K
YoY Change	-13.8%	2.19%	121.77%
Operating Profit	-$609.6K	-$372.6K	-$410.1K
YoY Change	-20.59%	-9.16%
Interest Expense	-$85.57K	$47.29K	-$4.210K
YoY Change	1932.54%	-1223.18%	35.81%
% of Operating Profit
Other Income/Expense, Net	-$142.7K	$4.100K	$135.8K
YoY Change	-165.32%	-96.98%	-47.16%
Pretax Income	-$837.9K	-$415.7K	-$278.5K
YoY Change	51.41%	49.29%	-1101.37%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$837.9K	-$415.7K	-$278.5K
YoY Change	51.41%	49.29%	-1101.37%
Net Earnings / Revenue	-807.46%	-164.5%	-254.9%
Basic Earnings Per Share		-$0.02
Diluted Earnings Per Share	-$0.04	-$17.80K	-$12.60K
COMMON SHARES
Basic Shares Outstanding	24.55M shares	23.15M shares	22.10M shares
Diluted Shares Outstanding		23.36M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$110.6K	$86.06K	$164.9K
YoY Change	46.12%	-47.8%	44.18%
Cash & Equivalents	$110.6K	$86.06K	$164.9K
Short-Term Investments
Other Short-Term Assets	$81.32K	$1.077M	$123.1K
YoY Change	-5.64%	774.51%
Inventory
Prepaid Expenses	$81.32K	$119.4K
Receivables			$0.00
Other Receivables		$0.00	$0.00
Total Short-Term Assets	$191.9K	$1.163M	$288.0K
YoY Change	18.56%	303.73%	151.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$50.00K
YoY Change
Goodwill	$740.5K	$740.5K
YoY Change	0.0%
Intangibles	$574.2K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$50.00K
YoY Change
Total Long-Term Assets	$1.365M	$1.325M	$1.327M
YoY Change	0.49%	-0.11%
TOTAL ASSETS
Total Short-Term Assets	$191.9K	$1.163M	$288.0K
Total Long-Term Assets	$1.365M	$1.325M	$1.327M
Total Assets	$1.557M	$2.488M	$1.615M
YoY Change	2.42%	54.07%	1312.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.266M	$2.132M	$1.775M
YoY Change	17.16%	20.09%	-4.33%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$2.211M	$2.577M	$450.0K
YoY Change	397.49%	472.66%
Total Short-Term Liabilities	$4.477M	$4.709M	$2.225M
YoY Change	88.24%	111.61%	3.23%
LONG-TERM LIABILITIES
Long-Term Debt	$139.1K	$139.1K	$157.4K
YoY Change	-11.61%	-11.61%	-18.29%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$139.1K	$139.1K	$157.4K
YoY Change	-11.61%	-11.61%	-18.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.477M	$4.709M	$2.225M
Total Long-Term Liabilities	$139.1K	$139.1K	$157.4K
Total Liabilities	$4.616M	$4.848M	$2.383M
YoY Change	82.04%	103.47%	1.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$39.53M	-$38.69M
YoY Change	16.72%
Common Stock	$36.47M	$36.33M
YoY Change	11.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.059M	-$2.360M	-$767.6K
YoY Change
Total Liabilities & Shareholders Equity	$1.557M	$2.488M	$1.615M
YoY Change	2.42%	54.07%	1312.4%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$837.9K	-$415.7K	-$278.5K
YoY Change	51.41%	49.29%	-1101.37%
Depreciation, Depletion And Amortization	$21.74K	$32.71K	$0.00
YoY Change	117.18%
Cash From Operating Activities	-$854.7K	-$178.1K	-$377.5K
YoY Change	32.11%	-52.81%	113.13%
INVESTING ACTIVITIES
Capital Expenditures	-$983.5K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%		-100.0%
Cash From Investing Activities	$983.5K	$0.00	$0.00
YoY Change	74.59%		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-104.2K	245.0K	0.000
YoY Change	1795.09%		-100.0%
NET CHANGE
Cash From Operating Activities	-854.7K	-178.1K	-377.5K
Cash From Investing Activities	983.5K	0.000	0.000
Cash From Financing Activities	-104.2K	245.0K	0.000
Net Change In Cash	24.55K	66.85K	-377.5K
YoY Change	-127.53%	-117.71%	-475.84%
FREE CASH FLOW
Cash From Operating Activities	-$854.7K	-$178.1K	-$377.5K
Capital Expenditures	-$983.5K	$0.00
Free Cash Flow	$128.8K	-$178.1K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001688126
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent		usd
CY2021Q4	CRCW	Fixed Assets FixedAssets		usd
CY2021Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets		usd
CY2021Q3	us-gaap	Depreciation Depreciation		usd
	us-gaap	Depreciation Depreciation		usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue		usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	CRCW	Issuance Of Common Stock For Acquisition IssuanceOfCommonStockForAcquisition		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates		usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt		usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55726
	dei	Entity Registrant Name EntityRegistrantName	THE CRYPTO COMPANY
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4212105
	dei	Entity Address Address Line1 EntityAddressAddressLine1	23823 Malibu Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	# 50477
	dei	Entity Address City Or Town EntityAddressCityOrTown	Malibu
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90265
	dei	City Area Code CityAreaCode	(424)
	dei	Local Phone Number LocalPhoneNumber	228-9955
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24546715	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	86061	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	75699	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	119425	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	86179	usd
CY2022Q3	CRCW	Fixed Assets FixedAssets	957181	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	1162667	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	161878	usd
CY2022Q3	us-gaap	Goodwill Goodwill	740469	usd
CY2021Q4	us-gaap	Goodwill Goodwill	740469	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	585002	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	617501	usd
CY2022Q3	us-gaap	Assets Assets	2488138	usd
CY2021Q4	us-gaap	Assets Assets	1519848	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2131732	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1933800	usd
CY2022Q3	us-gaap	Notes Payable Current NotesPayableCurrent	2576972	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	444500	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4708704	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2378300	usd
CY2022Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2022Q3	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	14100	usd
CY2021Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	32365	usd
CY2022Q3	us-gaap	Liabilities Liabilities	4847804	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2535665	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23482073	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23482073	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22205248	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22205248	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	23482	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	22205	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36310385	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32830496	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38693533	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-33868518	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2359666	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015817	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2488138	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1519848	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	252733	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	109252	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	515767	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	220397	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	94532	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	266292	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	158201	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	109252	usd
	us-gaap	Gross Profit GrossProfit	249475	usd
	us-gaap	Gross Profit GrossProfit	220397	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	305723	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	421974	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1414053	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1078343	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10833	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32499	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	22491	usd
CY2022Q3	us-gaap	Depreciation Depreciation	32708	usd
	us-gaap	Depreciation Depreciation	76319	usd
CY2022Q3	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	17875	usd
CY2021Q3	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	10187	usd
	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	272447	usd
	CRCW	Sharebased Compensation Employee SharebasedCompensationEmployee	12657	usd
CY2022Q3	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	163612	usd
CY2021Q3	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	87200	usd
	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	1693550	usd
	CRCW	Sharebased Compensation Nonemployee SharebasedCompensationNonemployee	418324	usd
CY2022Q3	us-gaap	Costs And Expenses CostsAndExpenses	530752	usd
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	519361	usd
	us-gaap	Costs And Expenses CostsAndExpenses	3488869	usd
	us-gaap	Costs And Expenses CostsAndExpenses	1531815	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-372551	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-410109	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3239394	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1311418	usd
CY2022Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4100	usd
CY2021Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	135842	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	85865	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	1091350	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	47286	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	4209	usd
	us-gaap	Interest Expense InterestExpense	1671486	usd
	us-gaap	Interest Expense InterestExpense	12158	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-415737	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-278476	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4825015	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-232226	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-415737	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-278476	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4825015	usd
	us-gaap	Net Income Loss NetIncomeLoss	-232226	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.02
CY2021Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.01
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.21
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.01
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23357250	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22104224	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22956299	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22028125	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2395647	usd
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	20929	usd
CY2021Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.00
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	825001	usd
	CRCW	Stock Compensation Expense In Connection With Issuance Of Common Stock StockCompensationExpenseInConnectionWithIssuanceOfCommonStock	410052	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	604317	usd
	us-gaap	Net Income Loss NetIncomeLoss	-232226	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-767575	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015817	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.28
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26240	usd
	CRCW	Stock Compensation Expense In Connection With Issuance Of Common Stock StockCompensationExpenseInConnectionWithIssuanceOfCommonStock	1922247	usd
	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	43750	usd
	CRCW	Adjustments To Additional Paid In Capital Debt Discount For Warrants AdjustmentsToAdditionalPaidInCapitalDebtDiscountForWarrants	1488928	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4825015	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2359666	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4825015	usd
	us-gaap	Net Income Loss NetIncomeLoss	-232226	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	108818	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	22491	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1965997	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	430981	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1488928	usd
	CRCW	Issuance Of Common Stock For Acquisition IssuanceOfCommonStockForAcquisition	604317	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	53493	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3900	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	33246	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	123113	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	197932	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-158128	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	21000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1075585	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	494730	usd
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	1349457	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1033500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1033500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1349457	usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	18265	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	-39265	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2132472	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	150000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	26240	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	825000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2119447	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	993265	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10362	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	138538	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	75699	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26326	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	86061	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	164864	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	21000	usd
CY2022Q3	us-gaap	Cash Cash	86061	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4825015	usd
	CRCW	Working Capital WorkingCapital	3546037	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38693533	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84E_eus-gaap--UseOfEstimates_zdO3hKm6wyBd" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Use of estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant estimates and assumptions include but are not limited to the valuation allowances of deferred taxes, and share-based compensation expenses. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on the Company’s operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	1349457	usd
	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	740469	usd
CY2022Q3	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	650000	usd
	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles	54166	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32499	usd
CY2022Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2281429	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281429	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.26
	CRCW	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Beginning Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingBeginningWeightedAverageRemainingContractualTerm2	P4Y3M
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5155003	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281429	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y6M
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5155003	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2281429	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y6M
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	5155003	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1339325	shares
CY2022Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
	us-gaap	Payments For Rent PaymentsForRent	0	usd
	us-gaap	Payments For Rent PaymentsForRent	0	usd

Files In Submission

Name	View Source	Status
0001493152-22-032030-index-headers.html	Edgar Link	pending
0001493152-22-032030-index.html	Edgar Link	pending
0001493152-22-032030.txt	Edgar Link	pending
0001493152-22-032030-xbrl.zip	Edgar Link	pending
crcw-20220930.xsd	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-1_001.jpg	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex10-2_001.jpg	Edgar Link	pending
ex10-3.htm	Edgar Link	pending
ex10-3_001.jpg	Edgar Link	pending
crcw-20220930_cal.xml	Edgar Link	unprocessable
crcw-20220930_def.xml	Edgar Link	unprocessable
crcw-20220930_lab.xml	Edgar Link	unprocessable
crcw-20220930_pre.xml	Edgar Link	unprocessable
ex10-4.htm	Edgar Link	pending
ex10-4_001.jpg	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-5_001.jpg	Edgar Link	pending
ex10-5_002.jpg	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-6_001.gif	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRCW
Crypto Co Stock $crcw

2022 Q4 Form 10-Q Financial Statement

#000149315222032030 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRCW Crypto Co Stock $crcw

2022 Q4 Form 10-Q Financial Statement

#000149315222032030 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRCW
Crypto Co Stock $crcw